CHMA Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 saus. 1970 @ 03:00):

Stats
Dzisiejszy wolumen	8.20M
Średni wolumen	996 380
Kapitalizacja rynkowa	0.00
EPS	$0 ( 2021-08-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.39
ATR14	$0.159 (4.23%)

Insider Trading

Date	Person	Action	Amount	type
2021-08-05	Stonepine Capital, L.p.	Sell	6 770 000	Common Stock
2021-08-05	Ludlam William	Sell	11 799	Common Stock
2021-08-05	Ludlam William	Sell	45 916	Stock Option (Right to Buy)
2021-08-05	Ludlam William	Sell	14 531	Stock Option (Right to Buy)
2021-08-05	Ludlam William	Sell	74 997	Stock Option (Right to Buy)

INSIDER POWER
0.00
Last 99 transactions
Buy: 1 667 356 \| Sell: 11 115 504

Wolumen Korelacja

Długi: 0.01 (neutral)

Krótki: -0.90 (very strong negative)

Signal:(31.756) Neutral

Chiasma, Inc. Korelacja

10 Najbardziej pozytywne korelacje
NKTX	0.909
CPLP	0.903
BHFAO	0.902
CLRB	0.9
BHFAP	0.899
IDYA	0.892
SOPH	0.888
AMD	0.887
FSTR	0.885
DWSH	0.885

10 Najbardziej negatywne korelacje
UBFO	-0.944
BLFY	-0.943
SPFI	-0.942
OZK	-0.942
CSML	-0.94
UNTY	-0.939
VBTX	-0.935
HWC	-0.935
DWMC	-0.934
HBCP	-0.934

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Chiasma, Inc. Korelacja - Waluta/Towar

0.49
( neutral )

-0.08
( neutral )

-0.51
( weak negative )

-0.19
( neutral )

-0.41
( neutral )

0.79
( moderate )

Chiasma, Inc. Finanse

Annual	2020
Przychody:	$1.11M
Zysk brutto:	$1.05M (94.48 %)
EPS:	$-1.430

FY	2020
Przychody:	$1.11M
Zysk brutto:	$1.05M (94.48 %)
EPS:	$-1.430

FY	2019
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-1.060

FY	2018
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-1.280

Financial Reports:

No articles found.

Chiasma, Inc.

Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.